| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_855134d24923e4495403f14ae53753a8 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6897 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate |
1997-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1cd1ef2da6a7e4aad2e06f7d12aa0afc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f7e8a68f4fe5542678c1884536d330cd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fecce0a70f11ef43a19f10d396df759f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_74b72945ff36b6075dffa3f10b5546b4 |
| publicationDate |
1999-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0918884-A1 |
| titleOfInvention |
Prostate cancer drug screening |
| abstract |
Screening of compounds for activity toward inhibition of prostate cancer cell proliferation is provided. A cell line is employed which can be used in conventional equipment for determining activity of compounds, where the cell line uses a marker whose expression is responsive to therapeutically active compounds. |
| priorityDate |
1996-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |